Sfoglia per Autore
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
2004 ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M.
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
2004 ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M.
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma.
2004 Zinzani P.L.; Pulsoni A.; Gentilini P.; Visani G.; Perrotti A.; Molinari A.L.; Guardigni L.; Tani M.; Valliva N.; Stefoni V.; Alinari L.; Martelli M.; Bonifazi F.; Pileri S.; Tura S.; Baccarani M.
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience
2004 ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M.; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M.
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
2004 ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma.
2005 Marchi E; Alinari L; Tani M; Stefoni V; Pimpinelli N; Berti E; Pagano L; Bernengo MG; Zaja F; Rupoli S; Pileri S; Baccarani M; Zinzani PL
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
2005 ISIDORI A; TANI M; BONIFAZI F; ZINZANI P; CURTI A; MOTTA MR; RIZZI S; GIUDICE V; FARESE O; ROVITO M; ALINARI L; CONTE R; BACCARANI M.; LEMOLI RM.
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma.
2005 Alinari L; Musuraca G; Tani M; Stefoni V; Gabriele A; Marchi E; Fina M; De Vivo A; Pileri S; Baccarani M; Zinzani PL
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma.
2005 Tani M; Fina M; Alinari L; Stefoni V; Baccarani M; Zinzani PL.
18 F-FDG PET in malignant lymphoma: significance of positive findings
2005 Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S.
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas.
2005 Stefoni V; Alinari L; Musuraca G; Tani M; Marchi E; Gabriele A; Fina M; Pileri S; Baccarani M; Zinzani PL.
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
2005 ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MARCHI E; FALINI B; BACCARANI M; PILERI SA.
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy.
2005 Zinzani PL; Tani M; Alinari L;Molinari AL;Stefoni V.;Visani G.; Gentilini P.; Guardigni L.; Fina M.; Baccarani M.
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma.
2005 ZINZANI PL; ALINARI L; TANI M; FINA M; PILERI S; BACCARANI M.
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia.
2006 Zaja F; Vianelli N; Battista M; Sperotto A; Patriarca F; Tomadini V; Fili C; Tani M; Baccarani M; Fanin R.
Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients.
2006 Alinari L.; Ambrosini V.; Castellucci P.; Tani M.; Stefoni V.; Nanni C.; Farsad M.; Rubello D.; Franchi R.; Zinzani P.L.; Fanti S.
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma.
2006 Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsad M; Franchi R; Fanti S; Zinzani PL.
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
2006 Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; Fina M.; Farshad M.; Pileri S.; Baccarani M.
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
2007 Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpiaz G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M.
FDG-PET in the serial assessment of patinets with lymphoma in complete remission
2007 V. Ambrosini; P.L. Zinzani; P. Castellucci; V. Stefoni; C. Nanni; M. Tani; M. Farsad; L. Alinari; D. Rubello; R. Franchi; S. Fanti
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. | ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M. | 2004-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine | ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. | Zinzani P.L.; Pulsoni A.; Gentilini P.; Visani G.; Perrotti A.; Molinari A.L.; Guardigni L.; Tani... M.; Valliva N.; Stefoni V.; Alinari L.; Martelli M.; Bonifazi F.; Pileri S.; Tura S.; Baccarani M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience | ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M....; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. | ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA ...G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M | 2004-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Gemcitabine as frontline treatment for cutaneous T-cell lymphoma. |
Marchi E; Alinari L; Tani M; Stefoni V; Pimpinelli N; Berti E; Pagano L; Bernengo MG; Zaja F; Ru...poli S; Pileri S; Baccarani M; Zinzani PL |
2005-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. | ISIDORI A; TANI M; BONIFAZI F; ZINZANI P; CURTI A; MOTTA MR; RIZZI S; GIUDICE V; FARESE O; ROVITO... M; ALINARI L; CONTE R; BACCARANI M.; LEMOLI RM. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma. | Alinari L; Musuraca G; Tani M; Stefoni V; Gabriele A; Marchi E; Fina M; De Vivo A; Pileri S; Bacc...arani M; Zinzani PL | 2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma. | Tani M; Fina M; Alinari L; Stefoni V; Baccarani M; Zinzani PL. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| 18 F-FDG PET in malignant lymphoma: significance of positive findings | Castellucci P.; Zinzani P.L.; Nanni C.; Farsad M.; Moretti A.; Alinari L.; Battista G.; Tani M.; ...Stefoni V.; Canini R.; Monetti N.; Rubello D.; Alavi A.; Franchi R.; Fanti S. | 2005-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. |
Stefoni V; Alinari L; Musuraca G; Tani M; Marchi E; Gabriele A; Fina M; Pileri S; Baccarani M; Z...inzani PL. |
2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. | ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MAR...CHI E; FALINI B; BACCARANI M; PILERI SA. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. | Zinzani PL; Tani M; Alinari L;Molinari AL;Stefoni V.;Visani G.; Gentilini P.; Guardigni L.; Fina ...M.; Baccarani M. | 2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. | ZINZANI PL; ALINARI L; TANI M; FINA M; PILERI S; BACCARANI M. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia. | Zaja F; Vianelli N; Battista M; Sperotto A; Patriarca F; Tomadini V; Fili C; Tani M; Baccarani M;... Fanin R. | 2006-01-01 | EXPERIMENTAL HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Discordant response to chemotherapy: An unusual patternof fluoro-deoxy-d-glucose uptake in heavily pre-treated lymphoma patients. | Alinari L.; Ambrosini V.; Castellucci P.; Tani M.; Stefoni V.; Nanni C.; Farsad M.; Rubello D.; F...ranchi R.; Zinzani P.L.; Fanti S. | 2006-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. |
Alinari L; Castellucci P; Elstrom R; Ambrosini V; Stefoni V; Nanni C; Berkowitz A; Tani M; Farsa...d M; Franchi R; Fanti S; Zinzani PL. |
2006-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. | Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; F...ina M.; Farshad M.; Pileri S.; Baccarani M. | 2006-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. | Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpia...z G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| FDG-PET in the serial assessment of patinets with lymphoma in complete remission | V. Ambrosini; P.L. Zinzani; P. Castellucci; V. Stefoni; C. Nanni; M. Tani; M. Farsad; L. Alinari;... D. Rubello; R. Franchi; S. Fanti | 2007-01-01 | - | Society of Nuclear Medicine | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile